We could not find any results for:
Make sure your spelling is correct or try broadening your search.
EINDHOVEN, the Netherlands, June 18, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to...
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Shareholders approve all proposed resolutions EINDHOVEN, the...
ONWARD® Medical berichtet über das 1. Quartal 2024 und die bisherigen Höhepunkte des Jahres Ergebnisse der Up-LIFT-Zulassungsstudie in Nature Medicine veröffentlicht Einreichung des...
Nature Medicine published Up-LIFT pivotal trial results Submitted FDA De Novo application for ARC-EX® System Successfully raised EUR 20M in equity capital EINDHOVEN, the Netherlands, May 23...
ONWARD® Medical organise une téléconférence pour partager les détails relatifs à son étude clinique Up-LIFT et à sa publication dans la revue Nature Medicine La revue Nature Medicine a publié...
ONWARD® Medical veranstaltet Webcast zu Einzelheiten der Up-LIFT-Studie und der aktuellen Veröffentlichung in Nature Medicine Ergebnisse der Up-LIFT-Zulassungsstudie in Nature Medicine...
Nature Medicine se réjouit de partager l’amélioration significative de la fonction de la main et du bras après une lésion de la moelle épinière grâce à la thérapie ONWARD® ARC-EX® Therapy La...
Nature Medicine hebt signifikante Verbesserung der Hand- und Armfunktion nach einer Rückenmarksverletzung durch die ONWARD® ARC-EX® Therapie hervor ARC Therapy™ hat sich in einer globalen...
ONWARD® Medical to Host Webcast to Share Details from its Up-LIFT Trial and Yesterday’s Nature Medicine Publication Nature Medicine published Up-LIFT pivotal trial results Company will...
Nature Medicine Highlights Significant Improvement in Hand and Arm Function After Spinal Cord Injury with Use of ONWARD® ARC-EX® Therapy ARC Therapy™ shown to be safe and effective in global...
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.17 | -3.37301587302 | 5.04 | 5.14 | 4.76 | 25970 | 4.87632584 | DE |
4 | -1.05 | -17.7364864865 | 5.92 | 6.18 | 4.76 | 48022 | 5.19705072 | DE |
12 | 0.08 | 1.67014613779 | 4.79 | 6.18 | 4.51 | 72490 | 5.29491324 | DE |
26 | 1.77 | 57.0967741935 | 3.1 | 6.58 | 1.85 | 92949 | 4.97253983 | DE |
52 | -0.69 | -12.4100719424 | 5.56 | 6.58 | 1.85 | 51398 | 4.85242387 | DE |
156 | -8.15 | -62.5960061444 | 13.02 | 13.28 | 1.85 | 25104 | 5.63051179 | DE |
260 | -8.15 | -62.5960061444 | 13.02 | 13.28 | 1.85 | 25104 | 5.63051179 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions